Genetic aberrations and progression-free survival in CLL patients treated with front line rituximab-based chemoimmunotherapy (FCR/BR): clinical practice experience

• Authors: ŠPUNAROVÁ Michaela; MALČÍKOVÁ Jitka; TOM Nikola; BORSKÝ Marek; BRYCHTOVÁ Yvona; DOUBEK Michael; PANOVSKÁ Anna; SKUHROVÁ FRANCOVÁ Hana; ĎURECHOVÁ Kristina; BRZOBOHATÁ A.; FREIBERGEROVÁ Anna; JAROŠOVÁ Marie; MRÁZ Marek; POSPÍŠILOVÁ Šárka; MAYER Jiří; TRBUŠEK Martin
• Year of publication: 2018
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine
• Description: Genetic aberrations and progression-free survival in CLL patients treated with front line rituximab-based chemoimmunotherapy (FCR/BR): clinical practice experience, Genetic aberrations and progression-free survival in CLL patients treated with front line rituximab-based chemoimmunotherapy (FCR/BR): clinical practice experience.

Related projects

• Predictive stratification of CLL patients for therapy involving monoclonal antibodies targeting CD20
• Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit V